How can AI revolutionize medical affairs and regulations?
Artificial intelligence (AI) significantly impacts many sectors, especially healthcare. It can enhance medical decision-making, Diagnosis, and treatment strategies. The worldwide healthcare market is projected to grow from .4 billion in 2019 to .02 billion in 2025. In the COVID-19 pandemic, artificial intelligence (AI) is used to identify and remove erroneous information, support virus monitoring, vaccine development, and risk assessment. Companies are spending millions on AI development. Improving patient outcomes and changing treatment approaches are the ultimate goals. NLP and machine learning (ML) algorithms are two subcategories of AI used in healthcare.
Utilizing Natural Language Processing (NLP) in Medical Affairs-
Decision-making is being improved, regulatory procedures are being transformed, and AI and machine learning are revolutionizing the medical industry. Global regulatory bodies are adopting AI/ML to optimize workflows, enhance healthcare quality, and simplify procedures, all while complying with the latest technology protocols.
AI and ML’s Place in Regulatory Operations
Because AI/ML presents a viable answer to regulatory issues, it has the potential to transform the regulatory processes of the medical industry completely.
- By quickly analyzing enormous datasets- AI algorithms help regulatory bodies make well-informed decisions by assisting them in spotting patterns, hazards, and abnormalities and precisely evaluating the safety and effectiveness of drugs.
- Regular regulatory chores like data entry- Document review and compliance monitoring are streamlined by AI-powered automation, lowering errors and expediting regulatory bodies’ procedures.
- By keeping regulatory bodies informed and quickly identifying deviations- Artificial intelligence (AI) improves compliance monitoring and lowers the likelihood of product recalls and legal infractions.
- Drug discovery powered by AI speeds up research while cutting expenses and time. ML algorithms enable quicker approval processes and more affordable drug delivery by analyzing biological data, identifying potential drugs, and predicting efficacy
AI Collaboration as Medical Affairs Develops
Medical affairs links the marketing, sales, and medical professionals who use pharmaceuticals and the drug development and research departments.
Medical Affairs also usually runs an information center to address unwanted product questions from medical practitioners. The period immediately following a market debut is very hectic for the information center.
Medical Affairs teams are achieving success in using AI-driven tools-
- Responding to Requests for Medical Information from Health Care Practitioners
- Analysis of Medical Congress Insights
- Scientific Meeting and Publication Planning
- Advice Council Perspectives
- Crucial Involvement of Opinion Leaders
Artificial Intelligence (AI) can help MedAffairs with regulatory compliance, competitor monitoring, and drug messaging comprehension. Four particular cases show how Medical Affairs issues can benefit from the successful application of NLP and AI, improving their capacity to adhere to regulations.
NLP & Text Analytics
Many components of Natural Language Processing (NLP), such as sentiment analysis, categorization, and named entity recognition, are built on top of text analytics. These NLP features, in general, seek to respond to the following four queries:
- Who is speaking?
- What subject are they discussing?
- What do they have to say about those topics?
- What emotions do they have?
Artificial Intelligence Will Impact Medical Affairs in 5 Ways
The pharmaceutical sector is becoming more interested in artificial intelligence (AI), as seen by the collaboration between Insilico Medicine and A2A Pharmaceuticals to research treatments for uncommon disorders like Duchenne muscular dystrophy(A hereditary illness known as Duchenne muscular dystrophy (DMD) is characterized by increasing muscle degeneration and weakening as a result of changes to the dystrophin protein, which is essential for maintaining intact muscle cells).
Stakeholder engagement, drug discovery, and competitive intelligence may all be transformed by AI’s ability to swiftly and precisely sort through massive volumes of data. Medical Affairs, in charge of interacting with external experts and key opinion leaders on behalf of stakeholders, can see changes to their role as Medical Science Liaisons (MSLs)(Within the pharmaceutical, biotechnology, medical device, CRO, and other healthcare businesses, there is a specialized function), the primary duty involved in interacting with external stakeholders.
Multi-Channel Outreach
Artificial intelligence will improve this by assisting MSLs in identifying the best channels of communication with external stakeholders and experts and the best times to meet with them. Additionally, businesses can evaluate MSL performance more accurately using objective benchmarks and critical indicators combined with advanced CRM and existing KOL profiling.
Clinical Investigations
MSLs frequently assist clinical recruiters in finding sites for commercial trials and in patient recruitment. More advanced algorithms and predictive analytics tools will be made possible by artificial intelligence, and these will be used to identify patients who are most likely to respond to therapies. Artificial intelligence will make it easier to collect data in real time and monitor patients more effectively.
Education and Training
Based on collected data, artificial intelligence will decide which learning styles are most beneficial for learners and adapt learning platforms accordingly. This will result in MSLs that have more successful and in-depth conversations with external stakeholders. For those working in medical affairs, this will also make training and professional growth more sustainable.
Drug Development
Medicine Development Information indicates that the average cost to bring a medicine to market is $2 billion. AI will reduce the expenses and time required to accomplish this. By more effectively sifting through vast volumes of data, artificial intelligence can also anticipate earlier in the drug development process whether or not a medication candidate would be successful.
Label Adding
Artificial intelligence can assist in identifying potential new indications for which a medication candidate could be best suited after receiving initial clearance by collecting vast amounts of data. Artificial intelligence has the potential to ascertain whether a given treatment is beneficial for a specific patient population based on tens of millions of data points that are available in a post-marketing setting.
AI Applications in Medical Affairs
- Insight Generation: AI tools can examine various data sources to find insights that might support MA’s purpose.
- Strategy formulation: After obtaining valuable insights, the MA team needs to decide how to use them and apply them to formulating a strategy. Here, AI could help MA teams with their strategic orientation by pointing out and recommending best practices and analogs.
- Evidence generating: In biopharma businesses, Massachusetts is fast becoming a center for evidence generating. AI’s ability to generate hypotheses and study designs could aid in the innovation of evidence generation.
AI solutions can enhance stakeholder involvement by optimizing engagement planning (i.e., identifying who to talk to and when) and recommending the optimum course of action for interacting with patients, patient advocacy groups, doctors, and other stakeholders.
- Communication: By utilizing AI techniques, MA teams may also be able to customize messages in real time for important stakeholders.
Link- https://bluematterconsulting.com/wp-content/uploads/2023/07/Fig-4-II.png
There is an AI tool that supports competitive intelligence and attendance at medical conferences. It is a sizable language model trained using terminology, literature, and data sets from the life sciences. The ultimate objective is to respond to user inquiries based on medical literature in a clinically and scientifically meaningful way. One initial application would be to attend a medical conference virtually, peruse posters, abstracts, presentations, transcripts, and posts on social media, and then compile and contrast the information shared there. These features could also be utilized routinely to monitor changes in the literature and the competitive environment.
- Enhanced Information Retrieval: Medical Affairs teams face a growing deluge of information from diverse sources. AI-powered search speeds up information retrieval for medical queries by combining machine learning and keyword recognition. Efficiency can be significantly increased, particularly for phone-based inquiries when prompt and correct responses are essential.
For example, an AI system can analyze past inquiries and FAQs, identify the most relevant responses, and display them at the top of the search results. This reduces reliance on manual searches and expedites response times while maintaining quality.
- Comparative Analysis Tools: Keeping track of updates and changes in treatment guidelines is a significant challenge. AI-powered differencing tools can automate this process. These tools can analyze new versions of treatment guidelines (like the NCCN Compendia) and highlight substantial changes compared to previous versions. This empowers medical professionals to quickly identify the latest recommendations and make informed prescribing decisions.
What Streamlining Effects Can AI Technologies Have on Medical Affairs Procedures?
The marketing of novel pharmaceuticals, which go through several stages of development before being commercialized, is crucial to pharmaceutical businesses. Commercial teams are under pressure since they require assistance from various departments in order to optimize their market strategies. Clinical and scientific expertise is provided by medical affairs teams, which are vital to the pharmaceutical industry. Developing connections with key opinion leaders (KOLs), disseminating information from clinical trials, assisting with research projects, and answering questions about product safety are just a few of their responsibilities. Prior to sending it to commercial teams for marketing, they also create a cogent medical strategy, guaranteeing adherence to medical messages and carrying it out via medical scientific liaisons (MSLs).
As internal medical experts, medical affairs specialists produce internal training materials and make sure all departments and team members are up to date on the most recent advancements in medicine. They also communicate the most recent advancements to outside stakeholders in their capacity as medical representatives. To find signs, new assets, and growth prospects, they collaborate with commercial teams.
Medical affairs teams play a critical role in the industry’s growth, and artificial intelligence may help them tremendously by centralizing and optimizing their job.
Using AI to assist with medical affairs
Using a customer-centric approach, the MA team has developed a tool to identify the primary obstacles facing medical affairs and use technology and domain expertise to address them, enabling this sector of the pharmaceutical industry to be empowered by artificial intelligence.
A significant quantity of medical information and coordination is managed by medical affairs. Considering how quickly medical innovation is developing, it can be necessary to keep up with the most recent findings across several databases. Nevertheless, there are frequent delays in getting the most recent data because the majority of databases are manually selected.
Dashboard for medical affairs overview
The medical department must handle massive medical data because it is a large industry. Therefore, accessing the most recent data is delayed because handling the enormous volume of data by hand is impossible. Thus, to address this problem, researchers created a medical affairs overview dashboard. Using proprietary technology, the dashboard centralizes relevant information from over 95% of publically available data, including KOL publications and changes to FDA guidelines. Medical Affairs can use the dashboard, which updates data continuously in real-time, to make well-informed business decisions.
Solution for KOL discovery
With the help of an AI tool, medical affairs staff can now access untapped Knowledge Organizations (KOLs) networks based on personalized parameters like geography, publications, and therapeutic area and illness subtypes. Researchers, pharma specialists, essential heads of medical societies, and thought leaders in the scientific and medical fields may all be easily ranked and prioritized using this platform.
A technique that leverages digital footprints and social media has been created by researchers to assist organizations in comprehending the viewpoints of physicians and patients. Using real-time patient opinions regarding pharmaceuticals, this technology can reveal unmet medical requirements and possible business prospects. Artificial intelligence systems that scan internet posts, reviews, forums, and comments from patients and doctors might reveal secret feedback, response rates, and unfavorable events. Examples of these techniques are sentiment analysis and natural language processing. Medical affairs teams in the pharmaceutical and life sciences sectors can streamline tasks and make decisions more quickly thanks to this centralized information. Better return on investment is achieved by the system’s identification of developing trends and thorough overviews of particular treatment areas. By giving pharmaceutical and life sciences companies information into patient attitudes and guidelines, the method makes medical challenges easier to understand.
Future Prediction
While the field of artificial intelligence is still in its infancy, and there are still many questions about which tools and applications will become the new norm, the field can potentially transform healthcare, especially Medical Affairs, altogether. The uncertain landscape may make it difficult for Medical Affairs teams to decide what to do. Considering the strict clinical and scientific standards that Medical Affairs experts must uphold, it is wise to proceed cautiously when exploring AI. When examining AI in the future, Medical Affairs teams should take three things into account-
- Medical Affairs should be ready to recognize and address any potential misconceptions when patients and other stakeholders begin using AI tools for their healthcare education.
- Utilize AI to discover safer, more efficient ways to function in Medical Affairs, specifically in light of the delicate nature of the work’s clinical and scientific components.
- Start talking with internal partners to understand better how future AI techniques fit into the larger corporate strategy and vision, such as commercial and other cross-functional stakeholders.
Ethical Considerations and Data Privacy
Using AI in healthcare brings up a number of important ethical issues. To fully realize the potential of AI, four crucial ethical concerns must be resolved: informed consent for data usage, data safety, transparency, algorithmic fairness, and data privacy. The debate over whether or not AI systems qualify as legal entities demands serious thought from legislators.
Openness of Algorithms:
Transparency of Algorithms: Transparency in algorithms is crucial, particularly in high-risk healthcare environments. For AI to be used ethically and be held accountable, it must be easily accessible and understandable. AI systems that are opaque and conceal their decision-making procedures put patient safety and accountability at risk.
Privacy and Informed Consent: The management of patient data is one of the main ethical issues. Because AI uses a lot of sensitive data, including medical records, it raises concerns about data privacy and informed permission. Patients need to know exactly how their data is being used, and security measures need to be in place to stop breaches and illegal access.
Algorithmic Fairness and Bias: Healthcare is not exempt from the widespread problem of bias in AI systems. Algorithm bias can result in discriminatory practices that impact patient outcomes and care. To guarantee equal healthcare delivery, bias in AI systems must be addressed. Achieving this goal requires regular audits and transparency in algorithm design. Transparency in algorithms is still another important issue. A lot of AI systems function as “black boxes,” which makes it challenging for patients and clinicians to comprehend the decision-making process. Gaining acceptance and establishing confidence requires making sure AI-driven recommendations are clear and understandable.
Accountability and Responsibility: As AI becomes more capable of making decisions on its own, it will become more difficult to assign blame. As AI systems malfunction or render inaccurate decisions, it is critical to ascertain who bears responsibility. Accountability is further complicated by the “black box” problem, in which users’ and assessors’ access to AI’s inner workings is restricted. Concerns regarding potential abuse and data breaches may arise from the application of AI in healthcare. The use of AI in cybersecurity and surveillance for national security may expose citizens’ fundamental rights to new threats.
Data Ownership: In Medical Affairs, who owns the data used to train AI models? This subject gets more complicated regarding partnerships between technology providers and pharmaceutical businesses. Agreements on data usage and ownership must be clear.
Data Security: Sensitive patient data may be compromised by hacks targeting AI systems. Robust data security protocols are necessary to safeguard patient data and maintain confidence in AI solutions.
Implementation Challenges
AI has great potential for the medical field, but putting that promise into practice is not without its share of difficulties. Let’s examine a few major obstacles that must be cleared: Data-related challenges:
Data Availability and Quality: For efficient training, many AI models need enormous volumes of high-quality data. It’s possible that Medical Affairs teams will only sometimes have access to transparent, consistent data sets that are large enough to build reliable AI models.
Data Integration: Medical data is frequently spread across multiple systems and stored in separate silos. Integrating this data from many sources into a format that AI can analyze can take a lot of work and effort.
Data Privacy Issues: As was previously mentioned, protecting patient privacy while using data to advance AI research is a significant concern. Achieving a balance between patient privacy and data utility is essential for the ethical application of AI.
Economic Impact
Through increased efficiency in diagnosis, operations, and treatment, AI-enabled healthcare can save substantial money for both patients and healthcare systems. Patients and healthcare providers benefit from this long-term financial return since it lessens the need for expensive operations and hospital stays. According to studies, incorporating AI might result in yearly savings in healthcare of between $200 billion and $360 billion.
Preventive healthcare with AI enhancements lowers medical costs by encouraging early disease detection and prompt interventions. Early detection of Parkinson’s disease reduces treatment expenses and improves patient quality of life. To address potential biases and concentrate on rapid results, research must be improved.
AI is also essential for cost containment, significantly lowering costs for healthcare providers and insurance organizations. Helping with compliance initiatives and lowering malpractice instances lowers litigation costs. Instruments such as Google DeepMind reduce the number of diagnostic mistakes that lead to malpractice lawsuits. Clinical Decision Support Systems (CDSSs), AI-driven clinical pathways, can dramatically reduce readmission rates, associated expenses, and fines. AI is swiftly emerging as a critical tool in drug discovery, offering a potential means of identifying innovative candidates and accelerating the development of new drugs. Third-party funding for AI-enabled medication research will top $5.2 billion by the end of 2021.
Artificial intelligence (AI) can significantly improve patient quality of life through more precise diagnosis, individualized treatment plans, accelerated recovery, and fewer issues by analyzing health data more rapidly and correctly than a human. By saving money on costly misdiagnoses and ineffective treatments, these advancements also help the economy.
Artificial intelligence (AI) has been used in research and innovation, especially medicine. It can drive technological breakthroughs and spin-off ideas that result in new healthcare products and services. On the other hand, new regulatory concerns could impede innovation or lower market competitiveness. In the healthcare sector, solid regulatory frameworks aid in balancing long-term economic projections with market risks.
few platforms that support the healthcare industry
AI is transforming healthcare by finding patterns in massive amounts of medical data and using that information to make diagnoses that are more precise. This is especially helpful in identifying complicated medical disorders that are difficult to identify with conventional techniques. This influence is demonstrated by successful deployments.
- IBM Watson Health:
IBM Watson Health is an AI-powered healthcare system that analyzes vast amounts of data, creates personalized treatment plans for patients — including cancer patients — and assists medical professionals in seeing possible health problems before they arise. It does this by using NLP and machine learning.
2.Google DeepMind:
Google DeepMind is an artificial intelligence (AI)-driven healthcare system that leverages deep learning to evaluate vast amounts of data, offer individualized treatment regimens, and forecast patient outcomes in critical care units. It is especially useful for patients with renal illness.
3. Maya AI
Maya AI places a high priority on data security and privacy by upholding stringent privacy standards and following industry best practices. It can save time and effort by translating regulatory documentation into plain English for medical practitioners. Insights into clinical trial results, regulatory filings, and medical information booklets can be arranged by Maya AI. With a 90% high-quality accuracy rate, Maya AI is constantly trying to become better. Clinical affairs specialists can access their data without specialized equipment or infrastructure because of its ability to connect to and analyze data from numerous internal and external silos.
4.Zebra Medical Vision:
Zebra Medical Vision is an AI-driven healthcare solution that improves diagnosis accuracy by analyzing medical images through deep learning. It has been applied to mammography and X-rays to detect possible breast cancer and osteoporosis.
5.Babylon Health:
Babylon Health is an AI-powered virtual healthcare assistant that uses natural language processing to deliver virtual consultations, individualized health recommendations, and answers to patient queries. It is especially useful for people with long-term diseases like diabetes.
6.AliveCor:
AliveCor is an AI-powered medical system that analyzes ECG data, looks for possible heart problems, and gives patients individualized treatment regimens. It does this by using deep learning.
7. IDx-DR:
With the use of deep learning to analyze retinal pictures(Retinal imaging is a medical process that involves taking a digital image of the retina, optic disc, and blood vessels located at the back of the eye.), IDx-DR is an AI-powered healthcare system that improves the detection of diabetic retinopathy and improves patient outcomes by identifying prospective cases of the condition.
For further information refer here
https://deasilex.com/how-will-ai-change-healthcare/
https://www.kolabtree.com/blog/5-real-world-examples-of-ai-in-healthcare/
https://bluematterconsulting.com/artificial-intelligence-healthcare-medical-affairs/
